DIRECT IN VIVO CRISPR SCREEN IDENTIFIES COOPERATING TUMOR SUPPRESSORS THAT DRIVE PROGRESSION OF IDH1-MUTANT LOW-GRADE GLIOMA TO AGGRESSIVE GLIOBLASTOMA

被引：0
|
作者：
Yanchus, Connor [1 ]
Drucker, Kristen [2 ]
Kollmeyer, Thomas [2 ]
Tsai, Ricky [3 ]
Jiang, Lingyan [3 ]
Ali, Asma [2 ]
Carson, Brittany [4 ]
Pawling, Judy [3 ]
Malik, Ahmad [1 ]
Al-Zahrani, Khalid [3 ]
Loganathan, Sampath Kumar [5 ]
Fortin, Jerome [6 ]
Zhou, Lily [6 ]
Elia, Andrew [6 ]
Dennis, James W. [3 ]
Mak, Tak [6 ]
Taylor, Michael [7 ]
Zadeh, Gelareh [1 ]
Dirks, Peter [7 ]
Jenkins, Robert [2 ]
Schramek, Daniel [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Mayo Clin, Rochester, MN USA
[3] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[4] INVIVO, Toronto, ON, Canada
[5] McGill Univ, Montreal, ON, Canada
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Hosp Sick Children, Toronto, ON, Canada
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TMOD-18
引用
收藏
页码：219 / 219
页数：1
相关论文
共 9 条
  • [1] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Mellinghoff, Ingo K.
    Lu, Min
    Wen, Patrick Y.
    Taylor, Jennie W.
    Maher, Elizabeth A.
    Arrillaga-Romany, Isabel
    Peters, Katherine B.
    Ellingson, Benjamin M.
    Rosenblum, Marc K.
    Chun, Saewon
    Le, Kha
    Tassinari, Ania
    Choe, Sung
    Toubouti, Youssef
    Schoenfeld, Steven
    Pandya, Shuchi S.
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer L.
    Cloughesy, Timothy F.
    NATURE MEDICINE, 2023, 29 (03) : 615 - +
  • [2] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Ingo K. Mellinghoff
    Min Lu
    Patrick Y. Wen
    Jennie W. Taylor
    Elizabeth A. Maher
    Isabel Arrillaga-Romany
    Katherine B. Peters
    Benjamin M. Ellingson
    Marc K. Rosenblum
    Saewon Chun
    Kha Le
    Ania Tassinari
    Sung Choe
    Youssef Toubouti
    Steven Schoenfeld
    Shuchi S. Pandya
    Islam Hassan
    Lori Steelman
    Jennifer L. Clarke
    Timothy F. Cloughesy
    Nature Medicine, 2023, 29 : 615 - 622
  • [3] TEXTILOMA RESEMBLING ANAPLASTIC PROGRESSION OF AN IDH1 MUTANT, LOW-GRADE GLIOMA
    Anderson, Mark D.
    Raghunathan, Aditya
    Aldape, Kenneth D.
    Fuller, Greg N.
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2012, 14 : 67 - 67
  • [4] Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Ingo K. Mellinghoff
    Min Lu
    Patrick Y. Wen
    Jennie W. Taylor
    Elizabeth A. Maher
    Isabel Arrillaga-Romany
    Katherine B. Peters
    Benjamin M. Ellingson
    Marc K. Rosenblum
    Saewon Chun
    Kha Le
    Ania Tassinari
    Sung Choe
    Youssef Toubouti
    Steven Schoenfeld
    Shuchi S. Pandya
    Islam Hassan
    Lori Steelman
    Jennifer L. Clarke
    Timothy F. Cloughesy
    Nature Medicine, 2024, 30 : 302 - 302
  • [5] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (vol 29, pg 615, 2023)
    Mellinghoff, Ingo K.
    Lu, Min
    Wen, Patrick Y.
    Taylor, Jennie W.
    Maher, Elizabeth A.
    Arrillaga-Romany, Isabel
    Peters, Katherine B.
    Ellingson, Benjamin M.
    Rosenblum, Marc K.
    Chun, Saewon
    Le, Kha
    Tassinari, Ania
    Choe, Sung
    Toubouti, Youssef
    Schoenfeld, Steven
    Pandya, Shuchi S.
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer L.
    Cloughesy, Timothy F.
    NATURE MEDICINE, 2024, 30 (01) : 302 - 302
  • [6] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (vol 29, pg 615, 2023)
    Mellinghoff, Ingo K.
    Lu, Min
    Wen, Patrick Y.
    Taylor, Jennie W.
    Maher, Elizabeth A.
    Arrillaga-Romany, Isabel
    Peters, Katherine B.
    Ellingson, Benjamin M.
    Rosenblum, Marc K.
    Chun, Saewon
    Le, Kha
    Tassinari, Ania
    Choe, Sung
    Toubouti, Youssef
    Schoenfeld, Steven
    Pandya, Shuchi S.
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer L.
    Cloughesy, Timothy F.
    NATURE MEDICINE, 2024, 30 (01) : 302 - 302
  • [7] The prognostic value of TP53 and tumor suppressor gene mutations in temozolomide-treated IDH1 mutant low-grade glioma
    Salem, Yahia E.
    Abu Alragheb, Bayan O.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] A PHASE 1, OPEN-LABEL, PERIOPERATIVE STUDY OF IVOSIDENIB (AG-120) AND VORASIDENIB (AG-881) IN RECURRENT, IDH1-MUTANT, LOW-GRADE GLIOMA: RESULTS FROM COHORT 1
    Mellinghoff, I. K.
    Wen, P. Y.
    Taylor, J. W.
    Maher, E. A.
    Arrillaga-Romany, I.
    Peters, K. B.
    Le, K.
    Tai, F.
    Steelman, L.
    Cloughesy, T. F.
    NEURO-ONCOLOGY, 2019, 21 : 2 - 2
  • [9] A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA
    Mellinghoff, Ingo
    Maher, Elizabeth
    Wen, Patrick
    Cloughesy, Timothy
    Peters, Katherine
    Choi, Changho
    Ellingson, Benjamin
    Lin, Alexander
    Li, Yan
    Soher, Brian
    Young, Robert
    Steelman, Lori
    Le, Kha
    Yin, Feng
    Wu, Bin
    Lu, Min
    Zhang, Yanwei
    Nicolay, Brandon
    Schoenfeld, Steven
    Yen, Katharine
    Pandya, Shuchi
    Clarke, Jennifer
    NEURO-ONCOLOGY, 2018, 20 : 234 - 234
1